It is a pharma private limited company based in New Delhi, Delhi, India, established in 2008.
2008 | New Delhi, Delhi, India | ActiveSirrus Pharmaceuticals Private Limited, a active private limited company, was established on 07 November 2008 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2008PTC184762. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Chandra Kanta Midha (Whole-Time Director), Hemant Kumar (Whole-Time Director), Vandana Midha (Whole-Time Director). Past directors included Chandra Kanta Midha, Hemant Kumar, Shyam Sunder Dua. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 153,Venus Appartment, Sector-9,Rohini, New Delhi, Delhi, 110085.
U24232DL2008PTC184762
184762
07 November 2008
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sirrus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandra Kanta Midha | Whole-Time Director | 12 Aug 2013 | Current |
| Hemant Kumar | Whole-Time Director | 25 May 2015 | Current |
| Vandana Midha | Whole-Time Director | 07 Nov 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2017 | Past |
| Pramod Abcsdd | Director | 20 Nov 2017 | Past |
| Pramod Abcsdd | Director | 12 Oct 2010 | Past |
| Pramod Abcsdd | Director | 20 Nov 2017 | Past |
| Pramod Abcsdd | Director | 12 Oct 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sirrus Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 26.62% decrease. The company also saw a slight improvement in profitability, with a 1.73% increase in profit. The company's net worth Soared by an impressive increase of 43.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sirrus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sirrus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sirrus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirrus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sirrus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Sirrus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Hemant Kumar was appointed as a Whole-time director was appointed as a Whole-time director on 25 May 2015 & has been associated with this company since 10 years 6 months . was completed.
The activity Chandra Kanta Midha was appointed as a Whole-time director was appointed as a Whole-time director on 12 Aug 2013 & has been associated with this company since 12 years 3 months . was completed.
Vandana Midha was appointed as a Whole-time director was appointed as a Whole-time director on 07 Nov 2008 & has been associated with this company since 17 years 25 days . was recorded as a recent event.
The activity Sirrus Pharmaceuticals Private Limited was registered on 07 Nov 2008 with Roc Delhi & aged 17 years 25 days as per MCA records. was completed.
The CIN of Sirrus Pharmaceuticals Private Limited is U24232DL2008PTC184762.
Sirrus Pharmaceuticals Private Limited is headquartered at 153,Venus Appartment, Sector-9,Rohini, New Delhi, Delhi, 110085.
Sirrus Pharmaceuticals Private Limited was incorporated on 07 November 2008.
The current directors of Sirrus Pharmaceuticals Private Limited are
The primary industry of Sirrus Pharmaceuticals Private Limited is Trade.
Sirrus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sirrus Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sirrus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX